Gerd Zettlmeissl
Vorsitzender bei MEDIGENE AG
Ursprung des Netzwerks ersten Grades von Gerd Zettlmeissl
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.
20
| Subsidiary | Miscellaneous Commercial Services | 20 |
15
| Public Company | Biotechnology | 15 |
12
| Public Company | Biotechnology | 12 |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria.
9
| Extinct | Pharmaceuticals: Major | 9 |
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
 MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. BiotechnologyHealth Technology MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. develops and researches vaccines. The joint venture company is based in Gurgaon, India. The company was founded in 2009. Raman Rao has been the CEO of the Indian company since 2020.
6
| Joint Venture | Biotechnology | 6 |
GlycoVaxyn AG
 GlycoVaxyn AG BiotechnologyHealth Technology GlycoVaxyn AG developed and produced bioconjugate vaccines. The company was founded in 2004 and was headquartered in Schlieren, Switzerland.
2
| Extinct | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gerd Zettlmeissl
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chairman | |
| University of Maryland | College/University | Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | President Chief Executive Officer Chief Tech/Sci/R&D Officer | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member Chief Operating Officer Founder | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Founder Chief Executive Officer | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Medigene Immunotherapies GmbH
 Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree | |
MSD Vaccines Ltd.
 MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Chairman Director/Board Member | |
| University of Vienna | College/University | Doctorate Degree Doctorate Degree | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Bath | College/University | Undergraduate Degree Undergraduate Degree | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Chairman Director/Board Member | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | President Chief Executive Officer | |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Founder Consultant / Advisor | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Université Libre de Bruxelles | College/University | Doctorate Degree Graduate Degree | |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
EyeD Pharma SA
 EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Medical Specialties | Founder Director/Board Member | |
| Solvay Business School of Economics & Management | College/University | Graduate Degree Graduate Degree | |
| UCB | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Corporate Officer/Principal | |
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Chief Executive Officer | |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member Chief Operating Officer | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Chief Operating Officer | |
| Basilea Pharmaceutical International Ltd. | Chief Executive Officer | ||
| University of Illinois | College/University | Doctorate Degree | |
| ABIVAX | Pharmaceuticals: Other | Director/Board Member | |
Noho.Care
 Noho.Care Packaged SoftwareTechnology Services Noho.Care is a Belgian company that specializes in no-code constructors and platforms. The private company is based in Woluwe-Saint-Lambert, Belgium. The company's technology allows for the creation of APIs at a much faster rate than traditional development methods. | Packaged Software | Director/Board Member | |
MaSTherCell SA
 MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member | |
Be Burger SA
 Be Burger SA RestaurantsConsumer Services Be Burger SA operates as a burger restaurant. The private company is based in Brussels, Belgium. | Restaurants | Director/Board Member | |
| Eurobiotech SA | Director/Board Member | ||
4 for Cells SRL
 4 for Cells SRL Data Processing ServicesTechnology Services 4 for Cells SPRL provides business outsourcing services. The private company is based in Hastière, Belgium. The Belgian company was founded in 2011. François Lesage has been the CEO of the company since 2011. | Data Processing Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 19 |
| Belgien | 13 |
| Schweiz | 6 |
| Deutschland | 5 |
| Vereinigtes Königreich | 5 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 13 |
| Commercial Services | 3 |
| Finance | 3 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 421 |
| Corporate Officer/Principal | 143 |
| Independent Dir/Board Member | 78 |
| Chief Executive Officer | 66 |
| Chairman | 59 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Marc Foidart | 38 |
| Regina Hodits | 34 |
| Jean-Paul Prieels | 32 |
| Iain Dukes | 30 |
| Michel Gréco | 28 |
| Graziano Seghezzi | 26 |
| David Ebsworth | 26 |
| Yves Jean Marie Désiront | 25 |
| James Sulat | 23 |
| David Lemus | 22 |
| Anne-Marie Graffin | 22 |
| R. Gordon Douglas | 21 |
| Lota Zoth | 20 |
| Philippe Dro | 18 |
- Börse
- Insiders
- Gerd Zettlmeissl
- Unternehmensverbindungen
